O	0	9	Oxidation	Oxidation	NN	B-NP
O	10	12	in	in	IN	B-PP
O	13	23	rheumatoid	rheumatoid	JJ	B-NP
O	24	33	arthritis	arthritis	NN	I-NP
O	33	34	.	.	.	O

O	35	41	Oxygen	Oxygen	NN	B-NP
O	42	52	metabolism	metabolism	NN	I-NP
O	53	56	has	have	VBZ	B-VP
O	57	59	an	an	DT	B-NP
O	60	69	important	important	JJ	I-NP
O	70	74	role	role	NN	I-NP
O	75	77	in	in	IN	B-PP
O	78	81	the	the	DT	B-NP
O	82	94	pathogenesis	pathogenesis	NN	I-NP
O	95	97	of	of	IN	B-PP
O	98	108	rheumatoid	rheumatoid	JJ	B-NP
O	109	118	arthritis	arthritis	NN	I-NP
O	118	119	.	.	.	O

O	120	128	Reactive	Reactive	JJ	B-NP
O	129	135	oxygen	oxygen	NN	I-NP
O	136	143	species	specie	NNS	I-NP
O	144	145	(	(	(	O
O	145	148	ROS	ROS	NN	B-NP
O	148	149	)	)	)	O
O	150	158	produced	produce	VBN	B-VP
O	159	161	in	in	IN	B-PP
O	162	165	the	the	DT	B-NP
O	166	172	course	course	NN	I-NP
O	173	175	of	of	IN	B-PP
B-Cell	176	184	cellular	cellular	JJ	B-NP
O	185	194	oxidative	oxidative	JJ	I-NP
O	195	210	phosphorylation	phosphorylation	NN	I-NP
O	210	211	,	,	,	O
O	212	215	and	and	CC	O
O	216	218	by	by	IN	B-PP
O	219	228	activated	activate	VBN	B-NP
B-Cell	229	239	phagocytic	phagocytic	JJ	I-NP
I-Cell	240	245	cells	cell	NNS	I-NP
O	246	252	during	during	IN	B-PP
O	253	262	oxidative	oxidative	JJ	B-NP
O	263	269	bursts	burst	NNS	I-NP
O	269	270	,	,	,	O
O	271	277	exceed	exceed	VBP	B-VP
O	278	281	the	the	DT	B-NP
O	282	295	physiological	physiological	JJ	I-NP
O	296	305	buffering	buffering	NN	I-NP
O	306	314	capacity	capacity	NN	I-NP
O	315	318	and	and	CC	O
O	319	325	result	result	VBP	B-VP
O	326	328	in	in	IN	B-PP
O	329	338	oxidative	oxidative	JJ	B-NP
O	339	345	stress	stress	NN	I-NP
O	345	346	.	.	.	O

O	347	350	The	The	DT	B-NP
O	351	360	excessive	excessive	JJ	I-NP
O	361	371	production	production	NN	I-NP
O	372	374	of	of	IN	B-PP
O	375	378	ROS	ROS	NN	B-NP
O	379	382	can	can	MD	B-VP
O	383	389	damage	damage	VB	I-VP
O	390	397	protein	protein	NN	B-NP
O	397	398	,	,	,	O
O	399	405	lipids	lipid	NNS	B-NP
O	405	406	,	,	,	O
O	407	414	nucleic	nucleic	JJ	B-NP
O	415	420	acids	acid	NNS	I-NP
O	420	421	,	,	,	O
O	422	425	and	and	CC	O
B-Cellular_component	426	432	matrix	matrix	NN	B-NP
I-Cellular_component	433	443	components	component	NNS	I-NP
O	443	444	.	.	.	O

O	445	449	They	They	PRP	B-NP
O	450	454	also	also	RB	B-ADVP
O	455	460	serve	serve	VBP	B-VP
O	461	463	as	as	IN	B-PP
O	464	473	important	important	JJ	B-NP
B-Immaterial_anatomical_entity	474	487	intracellular	intracellular	JJ	I-NP
O	488	497	signaling	signal	VBG	I-NP
O	498	507	molecules	molecule	NNS	I-NP
O	508	512	that	that	WDT	B-NP
O	513	520	amplify	amplify	VBP	B-VP
O	521	524	the	the	DT	B-NP
B-Multi-tissue_structure	525	533	synovial	synovial	JJ	I-NP
O	534	546	inflammatory	inflammatory	JJ	I-NP
O	546	547	-	-	HYPH	I-NP
O	547	560	proliferative	proliferative	JJ	I-NP
O	561	569	response	response	NN	I-NP
O	569	570	.	.	.	O

O	571	581	Repetitive	Repetitive	JJ	B-NP
O	582	588	cycles	cycle	NNS	I-NP
O	589	591	of	of	IN	B-PP
O	592	599	hypoxia	hypoxia	NN	B-NP
O	600	603	and	and	CC	I-NP
O	604	617	reoxygenation	reoxygenation	NN	I-NP
O	618	628	associated	associate	VBN	B-VP
O	629	633	with	with	IN	B-PP
O	634	641	changes	change	NNS	B-NP
O	642	644	in	in	IN	B-PP
B-Multi-tissue_structure	645	653	synovial	synovial	JJ	B-NP
O	654	663	perfusion	perfusion	NN	I-NP
O	664	667	are	be	VBP	B-VP
O	668	678	postulated	postulate	VBN	I-VP
O	679	681	to	to	TO	I-VP
O	682	690	activate	activate	VB	I-VP
O	691	698	hypoxia	hypoxia	NN	B-NP
O	698	699	-	-	HYPH	O
O	699	708	inducible	inducible	JJ	B-NP
O	709	715	factor	factor	NN	I-NP
O	715	716	-	-	HYPH	O
O	716	722	1alpha	1alpha	NN	B-NP
O	723	726	and	and	CC	O
O	727	734	nuclear	nuclear	JJ	B-NP
O	735	741	factor	factor	NN	I-NP
O	741	742	-	-	HYPH	B-NP
O	742	748	kappaB	kappaB	NN	I-NP
O	748	749	,	,	,	O
O	750	753	two	two	CD	B-NP
O	754	757	key	key	JJ	I-NP
O	758	771	transcription	transcription	NN	I-NP
O	772	779	factors	factor	NNS	I-NP
O	780	784	that	that	WDT	B-NP
O	785	788	are	be	VBP	B-VP
O	789	798	regulated	regulate	VBN	I-VP
O	799	801	by	by	IN	B-PP
O	802	809	changes	change	NNS	B-NP
O	810	812	in	in	IN	B-PP
B-Cell	813	821	cellular	cellular	JJ	B-NP
O	822	833	oxygenation	oxygenation	NN	I-NP
O	834	837	and	and	CC	I-NP
O	838	846	cytokine	cytokine	NN	I-NP
O	847	858	stimulation	stimulation	NN	I-NP
O	858	859	,	,	,	O
O	860	863	and	and	CC	O
O	864	868	that	that	DT	B-NP
O	869	871	in	in	IN	B-PP
O	872	876	turn	turn	NN	B-NP
O	877	888	orchestrate	orchestrate	VBP	B-VP
O	889	892	the	the	DT	B-NP
O	893	903	expression	expression	NN	I-NP
O	904	906	of	of	IN	B-PP
O	907	908	a	a	DT	B-NP
O	909	917	spectrum	spectrum	NN	I-NP
O	918	920	of	of	IN	B-PP
O	921	926	genes	gene	NNS	B-NP
O	927	935	critical	critical	JJ	B-ADJP
O	936	938	to	to	TO	B-PP
O	939	942	the	the	DT	B-NP
O	943	954	persistence	persistence	NN	I-NP
O	955	957	of	of	IN	B-PP
O	958	967	synovitis	synovitis	NN	B-NP
O	967	968	.	.	.	O

O	969	971	An	An	DT	B-NP
O	972	985	understanding	understanding	NN	I-NP
O	986	988	of	of	IN	B-PP
O	989	992	the	the	DT	B-NP
O	993	1000	complex	complex	JJ	I-NP
O	1001	1013	interactions	interaction	NNS	I-NP
O	1014	1022	involved	involve	VBN	B-VP
O	1023	1025	in	in	IN	B-PP
O	1026	1031	these	these	DT	B-NP
O	1032	1040	pathways	pathway	NNS	I-NP
O	1041	1046	might	might	MD	B-VP
O	1047	1052	allow	allow	VB	I-VP
O	1053	1056	the	the	DT	B-NP
O	1057	1068	development	development	NN	I-NP
O	1069	1071	of	of	IN	B-PP
O	1072	1077	novel	novel	JJ	B-NP
O	1078	1089	therapeutic	therapeutic	JJ	I-NP
O	1090	1100	strategies	strategy	NNS	I-NP
O	1101	1104	for	for	IN	B-PP
O	1105	1115	rheumatoid	rheumatoid	JJ	B-NP
O	1116	1125	arthritis	arthritis	NN	I-NP
O	1125	1126	.	.	.	O

